February is heart month, and technology is making it easier to self-monitor heart health. About one in five Americans use a ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

The majority of U.S. adults use a device on a regular basis to monitor their heart health, but only one in four uses those ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Moreover, the FDA cleared Tempus’ xT CDx. This is a 648-gene tumor profiling test. The FDA also cleared its ECG-AF algorithm, which is used for cardiac risk assessment. CMS followed by approving ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Tempus AI. Looking at options history for Tempus AI TEM we detected 21 trades. If we consider the specifics of each ...

DeepSeek, a Chinese AI company, has emerged as a formidable player in the artificial intelligence landscape, particularly with its cost-efficient large language models (LLMs). Unlike expensive U.S ...

Everyone with high blood pressure (typically 130/80 mmHg or higher) should monitor their blood pressure at home, as per the American Heart Association. It's essential because the tracking can help ...

Everybody should get a proper work-up." This includes "a heart monitor echocardiogram, etc, to make sure that there is no organic, physical problem with the heart that could be causing them their ...

Rhaeos moved into Fulton Labs in January, effectively moving its headquarters from Evanston to Chicago. The company employs 17 people, most of whom work out of the Fulton Labs office — the others are ...

monitoring capability up to 36 months; possibility to record asymptomatic arrhythmias automatically Limits monitoring limited to 24–48 hours; size may prevent activities that may trigger the ...